Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | CA9 | Q16790 | 1/20 | 0.61 |
| ▸ | STAT3 | P40763 | 1/20 | 0.44 |
| ▸ | MMP1 | P03956 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.44 |
| ▸ | MMP3 | P08254 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | ALPL | P05186 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11504379 | 0.92 | CA12 (0.54) | CA12CA1CA2CA9STAT3 | |
| SCHEMBL14155210 | 0.90 | CA12 (0.52) | CA12CA1CA2CA9STAT3 | |
| SCHEMBL11596849 | 0.87 | — | — | |
| SCHEMBL8167869 | 0.85 | ALDH1A1 (0.55) | CA12CA1CA2CA9STAT3 | |
| SCHEMBL10488617 | 0.85 | — | — | |
| SCHEMBL21351803 | 0.84 | CA12 (0.47) | CA12CA1CA2CA9STAT3 | |
| SCHEMBL11507848 | 0.81 | MEN1 (0.50) | CA12CA1CA2CA9STAT3 | |
| SCHEMBL26126387 | 0.81 | ADH1B (0.44) | CA12CA1CA2CA9STAT3 | |
| SCHEMBL13810457 | 0.80 | — | — | |
| SCHEMBL3610449 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106939248-B | Water-based carbon deposit cleaning composition for automobile | Foshan city cloud Technology Co. Ltd. (CN) | 2019-12-10 | — | — | CN | disclosed |
| US-10077336-B2 | Functionalized highly branched melamine-polyamine polymers | BASF SE (DE) | 2018-09-18 | — | — | US | disclosed |
| US-8466221-B2 | Polyamides that resist heat-aging | BASF SE (DE) | 2013-06-18 | — | — | US | disclosed |
| US-20120252987-A1 | FUNCTIONALIZED HIGHLY BRANCHED MELAMINE-POLYAMINE POLYMERS | BASF SE (DE) | 2012-10-04 | — | — | US | disclosed |
| US-20110257321-A1 | HIGHLY BRANCHED POLYAMINES AND OLIGOAMINES AS CORROSION INHIBITORS | BASF SE (DE) | 2011-10-20 | — | — | US | disclosed |
| US-20110224347-A1 | POLYAMIDES THAT RESIST HEAT-AGING | BASF SE (DE) | 2011-09-15 | — | — | US | disclosed |
| US-20110028603-A1 | HYPERBRANCHED POLYMERS AND OLIGOMERS COMPRISING TERMINAL AMINO GROUPS AS CURING AGENTS FOR EPOXY RESINS | BASF SE (DE) | 2011-02-03 | — | — | US | disclosed |
| US-4125614-A | DIURETIC | HOECHST AKTIENGESELLSCHAFT (DE) | 1978-11-14 | — | — | US | disclosed |
| US-4061761-A | Thiazolidine derivatives | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120252987-A1 | FUNCTIONALIZED HIGHLY BRANCHED MELAMINE-POLYAMINE POLYMERS | PARN, INMT, SRM | CA12 545/4885CA1 497/4885CA2 928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.